In the news release, "Ellomay Capital Reports Results for the
Three Months Ended March 31, 2024,"
issued on June 30, 2024 (15:30 ET) by Ellomay Capital over PR Newswire, we
are advised by the company that certain results inadvertently
included in the "Operating Segments" table should be replaced as
follows: (1) in the column titled "Dorad": Revenues - €14,392
instead of €64,139, Operating expenses - €(10,290) instead of
€(47,444), Depreciation expenses - €(1,308) instead of €(5,704),
Gross profit (loss) - €2,794 instead of €10,991 and Adjusted gross
profit (loss) - €2,794 instead of €10,991, (2) in the column titled
"Total reportable segments": Revenues - €22,923 instead of €72,670,
Operating expenses - €(14,936) instead of €(52,090), Depreciation
expenses - €(5,386) instead of €(9,782), Gross profit (loss) -
€2,601 instead of €10,798 and Adjusted gross profit (loss) - €971
instead of €9,168 and (3) in the column titled "Reconciliations":
Revenues - €(14,680) instead of €(64,427), Operating expenses -
€10,373 instead of €47,527, Depreciation expenses - €1,331 instead
of €5,727, Gross profit (loss) - €(2,976) instead of €(11,173) and
Adjusted gross profit (loss) - €(1,346) instead of €(9,543).
Complete, corrected release follows:
Ellomay Capital Reports Results for the Three Months Ended March
31, 2024
TEL-AVIV, Israel, June 30,
2024 /PRNewswire/ -- Ellomay Capital Ltd.
(NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the
"Company"), a renewable energy and power generator and
developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited financial
results for the three month period ended March 31, 2024.
Financial Highlights
- Total assets as of March 31, 2024
amounted to approximately €666.8 million, compared to total assets
as of December 31, 2023 of
approximately €612.9 million.
- Revenues1 for the three months ended
March 31, 2024 were approximately
€8.2 million, compared to revenues of approximately €11.7 million
for the three months ended March 31,
2023.
- Loss from continuing operations for the three months ended
March 31, 2024 was approximately €4.6
million, compared to net profit from continuing operations of
approximately €3 million for the three months ended March 31, 2023. Loss for the three months ended
March 31, 2024 was approximately €4.9
million, compared to net profit of approximately €3.3 million for
the three months ended March 31,
2023.
- EBITDA for the three months ended March
31, 2024 was approximately €1.6 million, compared to EBITDA
of approximately €4.2 million for the three months ended
March 31, 2023. See below under "Use
of Non-IFRS Financial Measures" for additional disclosure
concerning EBITDA.
- On December 31, 2023, the Company
executed an agreement to sell its holdings in the 9 MW solar plant
located in Talmei Yosef. The sale was consummated following
the balance sheet date, on June 3,
2024, and the net consideration received at closing was
approximately NIS 42.6 million
(approximately €10.6 million). In connection with the expected
sale, the Company presents the results of this solar plant as a
discontinued operation and the results for the three months ended
March 31, 2023 were adjusted
accordingly.
Financial Overview for the Three Months Ended March 31, 2024
- Revenues were approximately €8.2 million for the three months
ended March 31, 2024, compared to
approximately €11.7 million for the three months ended March 31, 2023. The decrease in revenues
mainly results from the decrease in electricity prices in
Spain.
- Operating expenses were approximately €4.6 million for the
three months ended March 31, 2024,
compared to approximately €6.4 million for the three months ended
March 31, 2023. The decrease in
operating expenses mainly results from a decrease in direct taxes
on turnover paid by the Company's Spanish subsidiaries as a result
of reduced electricity prices. The operating expenses of the
Company's Spanish subsidiaries for the three months ended
March 31, 2023 were impacted by the
Spanish RDL 17/2022, which established the reduction of returns on
the electricity generating activity of Spanish production
facilities that do not emit greenhouse gases, accomplished through
payments of a portion of the revenues by the production facilities
to the Spanish government. Depreciation and amortization expenses
were approximately €4.1 million for the three months ended
March 31, 2024, compared to
approximately €4 million for the three months ended March 31, 2023.
- Project development costs were approximately €1.4 million for
the three months ended March 31,
2024, compared to approximately €1.2 million for the three
months ended March 31, 2023. The
increase in project development costs is mainly due to development
expenses in connection with solar projects in the USA, Italy,
and Israel.
- General and administrative expenses were approximately €1.6
million for the three months ended March 31,
2024, compared to approximately €1.4 million for the three
months ended March 31, 2023. The
increase in general and administrative expenses is mostly due to
higher consultancy expenses.
- The Company's share of profits of equity accounted investee,
after elimination of intercompany transactions, was approximately
€1.3 million for the three months ended March 31, 2024, compared to approximately €1.2
million for the three months ended March 31,
2023. The increase in share of profits of equity accounted
investee was mainly due to lower financing expenses incurred by
Dorad for the period as a result of the CPI indexation of loans
from banks.
- Financing expenses, net, were approximately €3.3 million for
the three months ended March 31,
2024, compared to financing income of approximately €1.7
million for the three months ended March 31,
2023. The increase in financing expenses, net, was mainly
attributable to expenses resulting from exchange rate differences
amounted to approximately €0.5 million for the three months ended
March 31, 2024, compared to income
resulting from exchange rate differences of approximately €4.4
million for the three months ended March 31,
2023, an aggregate change of approximately €5.1 million. The
exchange rate differences were mainly recorded in connection with
the New Israeli Shekel ("NIS") cash and cash equivalents and
the Company's NIS denominated debentures and were caused by the
0.8% appreciation of the NIS against the euro during the three
months ended March 31, 2024, compared
to a 4.8% devaluation of the NIS against the euro during the three
months ended March 31, 2023. The
increase in financing expenses was partially offset by an increase
in financing income of approximately €0.5 million in connection
with derivatives and warrants in the three months ended
March 31, 2024, compared to the three
months ended March 31, 2023.
- Tax benefit was approximately €0.8 million for the three months
ended March 31, 2024, compared to
taxes on income of approximately €1.4 million in three months ended
March 31, 2023. The change in tax is
mainly due to deferred tax recorded in connection with carry
forward loss for which deferred tax were not previously recorded,
partially offset by the decrease in electricity prices in
Spain, resulting in lower taxable
income of the Company's Spanish subsidiaries.
- Loss from discontinued operation (net of tax) was approximately
€0.3 million for the three months ended March 31, 2024, compared to a profit from
discontinued operation of approximately €0.2 million for the three
months ended March 31, 2023.
- Loss for the three months ended March
31, 2024 was approximately €4.9 million, compared to net
profit of approximately €3.3 million for the three months ended
March 31, 2023.
- Total other comprehensive income was approximately €12 million
for three months ended March 31,
2024, compared to total other comprehensive loss of
approximately €26.6 million in three months ended March 31, 2023. The change in total other
comprehensive loss mainly results from changes in fair value of
cash flow hedges, including a material decrease in the fair value
of the liability resulting from the financial power swap that
covers approximately 80% of the output of the Talasol solar
plant (the "Talasol PPA"). The Talasol PPA experienced a
high volatility due to the substantial change in electricity prices
in Europe. In accordance with
hedge accounting standards, the changes in the Talasol PPA's fair
value are recorded in the Company's shareholders' equity through a
hedging reserve and not through the accumulated deficit/retained
earnings. The changes do not impact the Company's consolidated net
profit/loss or the Company's consolidated cash flows.
- Total comprehensive income was approximately €7.1 million for
the three months ended March 31,
2024, compared to total comprehensive loss of approximately
€29.9 million for the three months ended March 31, 2023.
- EBITDA was approximately €1.6 million for the three months
ended March 31, 2024, compared to
approximately €4.2 million for the three months ended March 31, 2023.
- Net cash from operating activities was approximately €1.2
million for the three months ended March 31,
2024, compared to approximately €1.8 million for the three
months ended March 31, 2023.
- On January 16, 2024, the Company
issued in an Israeli public offering units consisting of an
aggregate principal amount of NIS 170 million of its newly
issued Series F Debentures, due March 31,
2030, and the Series 2 Options to purchase an aggregate of
1,020,000 ordinary shares at a price per share of NIS 80 (subject to customary adjustments), which
expire on January 5, 2028. The net
proceeds of the offering, net of related expenses such as
consultancy fee and commissions, were approximately NIS 165 million (approximately €40 million as of
the issuance date).
On April 17, 2024, the Company issued
NIS 40 million par value of the
Series F Debentures in a private placement to Israeli classified
investors for an aggregate gross consideration of approximately
NIS 37.8 million (approximately €9.4
million as of the issuance date), reflecting a price of
NIS 0.946 per NIS 1 principal amount of the Series F
Debentures. Following completion of the private placement, the
aggregate outstanding par value of the Company's Series F
Debentures is NIS 210 million.
CEO Review for the First Quarter of 2024
Revenues in the first quarter of 2024 were approximately €8.2
million, compared to revenues of approximately €11.7 million in the
corresponding quarter last year. Most of the decrease in revenues
was due to the drop in prices in Spain, which subtracted approximately €3
million from the revenues.
Operating expenses in the first quarter of 2024 decreased by
approximately €1.8 million compared to the corresponding quarter
last year. Project development expenses in the first quarter of
2024 increased by approximately €0.3 million compared to the
corresponding quarter last year. Project development expenses
included non-recurring expenses of approximately €0.8 million.
Excluding such non-recurring expenses, there was a decrease in
project development expenses.
Activity in Spain:
In May 2024, the Ellomay Solar
project (capacity of 28 MW) reached financial closing of project
finance in the amount of €10 million for 16 years at an annual
interest rate, fixed through an interest rate swap deal, of
approximately 3%. After receiving the financing, the majority of
the equity invested in the project was returned.
In the first quarter of 2024, the trend of a strong decrease in
electricity prices in Europe
continued, with the exception of Italy where prices remained stable. The
decrease in electricity prices in Spain was approximately 70% compared to the
corresponding quarter in 2023. The most significant decrease was in
March 2024, in which prices decreased
by approximately 90% compared to the corresponding quarter in 2023.
The main reasons for the decrease in prices in Spain during the first quarter are the
relatively warm winter by 6 to 8 degrees (Celsius) above average on
the one hand and substantial rainfall that caused a sharp increase
in hydroelectric power generation on the other hand, when in March
alone the power generation from hydro sources jumped from 2000 GW
in the corresponding month in 2023 to 4700 GW. The high output of
hydroelectricity also caused a corresponding decrease in the prices
of green certificates. A return to normative prices was recorded
only in June 2024. In the Company's
estimation, this is an unusual event that affected the entire
electricity sector in Europe.
Despite the significant drop in electricity prices in
Spain, the Company's revenues from
the sale of electricity in Spain
for the first quarter of 2024 did not decrease at the same rate,
and stood at approximately €4.2 million, compared to revenues of
approximately €7.2 million in the corresponding quarter last year.
The main reason for the significant drop in electricity prices in
Spain not fully impacting the
Company's revenues is that most of the electricity the Company
sells in Spain is under a
long-term PPA.
Activity of Dorad:
In the first quarter of 2024, the Dorad power plant recorded an
increase in profit, with net profit of approximately NIS 65.6 million, an increase of approximately
NIS 11.7 million compared to the
corresponding quarter last year. The Dorad power station received
the approval of the National Infrastructures Committee and a
positive connection survey to increase the capacity by an
additional 650 MW. In addition, as of July
1, 2024, the power plant will participate in the system
manager's supply tenders.
Activity in the USA:
In the USA, the development and
construction activities of solar projects are progressing at a
rapid pace and the construction of the first four projects, with a
total capacity of approximately 49 MW, began in early 2024.
Completion of construction and connection to the grid of two
projects (in an aggregate capacity of approximately 27 MW) is
expected by the end of 2024 and of the other two projects (in an
aggregate capacity of approximately 22 MW) is expected in early
2025. Additional projects with an aggregate capacity of
approximately 30-40 MW intended for construction in 2025 are under
development.
Activity in Italy:
In Italy, the construction of a
solar project with a capacity of approximately 18 MW (ELLO 10) has
begun, and its construction is expected to be completed in
September 2024, this is in addition
to solar projects with a capacity of 20 MW whose construction has
been completed. Of the 20 MW whose construction has been completed,
10 MW were connected to the grid in the first quarter of 2024 and
another 10 MW are expected to be connected soon. Therefore, the
increase in income from the sale of electricity in Italy will be reflected mainly in the second
half of 2024. The construction prices of solar projects in
Italy are declining from record
levels of approximately €900 thousand per MW to approximately €675
thousand as of today, and the trend may continue. The Company is
negotiating with the contractor for construction agreements
adjusted to the new market prices. In addition to the 20 MW built
and the 18 MW under construction, the Company has 467 MW of solar
projects under development, of which 165 MW are ready for
construction and 302 MW are in very advanced stages.
New legislation in Italy
prohibits the establishment of new projects on agricultural land.
This prohibition increases the value of the Company's portfolio,
which is not located on agricultural land. The Company estimates
that new possibilities are emerging for obtaining a PPA in
Italy, therefore it is expected
that project financing will be possible more easily and at lower
costs. Considering these developments, and the decrease in
construction costs, the Company believes that its decision to slow
down the pace of construction commencements to meet lower
construction and financing costs was correct. Electricity prices in
Italy maintain a stable level.
Italy is the only country in
Europe where no negative
electricity prices were recorded. The main reason is local
gas-based electricity generation, and no change is expected in the
short and medium term.
Activity in Israel:
The Manara Cliff Pumped Storage Project (Company's share is
83.34%): A project with a capacity of 156 MW, which is in
advanced construction stages. The Iron Swords War, which commenced
on October 7, 2023, stopped the
construction work on the project. The project has protection from
the state for damages and losses due to the war within the
framework of the tariff regulation (covenants that support
financing). The project was expected to reach commercial operation
during the first half of 2027 and the continuation of the Iron
Swords war will cause a delay in the date of activation. The
Israeli Electricity Authority currently approved a postponement of
ten months of the dates for the project. The Company and its
partner in the project, Ampa, invested the equity required for the
project (other than linkage differences), and the remainder of the
funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately
NIS 1.18 billion.
Development of Solar licenses combined with storage:
- The Komemiyut and Qelahim Projects: each intended
for 21 solar MW and 50 MW / hour batteries. The sale of electricity
will be conducted through a private supplier. Commencement of
construction is planned for the first quarter of 2025.
The Company waived the rights it won in a solar / battery tender
process in connection with these projects and therefore paid a
forfeiture of guarantee in the amount of NIS
1.8 million and is in advanced negotiations with a local
supplier for the execution of a long-term PPA.
- The Talmei Yosef Project: intended for 10 solar MW
and 22 MW / hour batteries. The request for zoning approval was
approved in the fourth quarter of 2023.
- The Talmei Yosef Storage Project in Batteries:
there is a zoning approval for approximately 400 MW / hour. The
project is designed for the regulation of high voltage
storage.
The Company also has approximately 46 solar MW under preliminary
planning stages.
Activity in the
Netherlands:
During the first quarter of 2024, the operational improvement in
the Company's biogas plants continued and high production levels
were maintained. In addition, significant progress was made in the
process of obtaining the licenses to increase production by about
50% in the three plants. Increasing production will require only
small investments and is expected to increase income and EBITDA.
The establishment of the new government in the Netherlands enables the continuation of
the legislative process mandating the obligation to mix green gas
with fossil gas and the conclusion of the legislative process is
expected soon. This legislation is expected to have a positive
effect on the prices of green gas and the price of the accompanying
green certificates.
Use of Non-IFRS Financial Measures
EBITDA is a non-IFRS measure and is defined as earnings before
financial expenses, net, taxes, depreciation and amortization. The
Company presents this measure in order to enhance the understanding
of the Company's operating performance and to enable comparability
between periods. While the Company considers EBITDA to be an
important measure of comparative operating performance, EBITDA
should not be considered in isolation or as a substitute for net
income or other statement of operations or cash flow data prepared
in accordance with IFRS as a measure of profitability or liquidity.
EBITDA does not take into account the Company's commitments,
including capital expenditures and restricted cash and,
accordingly, is not necessarily indicative of amounts that may be
available for discretionary uses. Not all companies calculate
EBITDA in the same manner, and the measure as presented may not be
comparable to similarly-titled measure presented by other
companies. The Company's EBITDA may not be indicative of the
Company's historic operating results; nor is it meant to be
predictive of potential future results. The Company uses this
measure internally as performance measure and believes that when
this measure is combined with IFRS measure it add useful
information concerning the Company's operating performance. A
reconciliation between results on an IFRS and non-IFRS basis is
provided on page 18 of this press release.
About Ellomay Capital Ltd.
Ellomay is an Israeli based company whose shares are listed on
the NYSE American and the Tel Aviv Stock Exchange under the trading
symbol "ELLO". Since 2009, Ellomay Capital focuses its
business in the renewable energy and power sectors in Europe, USA
and Israel.
To date, Ellomay has evaluated numerous opportunities and
invested significant funds in the renewable, clean energy and
natural resources industries in Israel, Italy, Spain,
the Netherlands and Texas, USA, including:
- Approximately 335.9 MW of photovoltaic power plants in
Spain (including a 300 MW
photovoltaic plant in owned by Talasol, which is 51% owned by the
Company) and approximately 9.95 MW of photovoltaic power plants in
Italy;
- 9.375% indirect interest in Dorad Energy Ltd., which owns
and operates one of Israel's
largest private power plants with production capacity of
approximately 850MW, representing about 6%-8% of Israel's total current electricity
consumption;
- Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas
Gelderland B.V., project companies operating anaerobic digestion
plants in the Netherlands,
with a green gas production capacity of approximately 3 million,
3.8 million and 9.5 million Nm3 per year, respectively;
- 83.333% of Ellomay Pumped Storage (2014) Ltd., which is
involved in a project to construct a 156 MW pumped storage hydro
power plant in the Manara Cliff, Israel;
- A photovoltaic plant with installed capacity of
approximately 10 MW in the Lazio Region, Italy that is ready for connection to the
grid;
- Ellomay Solar Italy Ten SRL that is construction a photovoltaic
plant (18 MW) in Italy;
- Ellomay Solar Italy Four SRL (15.06 MW), Ellomay Solar Italy
Five SRL (87.2 MW), Ellomay Solar Italy Seven SRL (54.77 MW),
Ellomay Solar Italy Nine SRL (8 MW) and Ellomay Solar Italy Fifteen
SRL (10 MW) that are developing photovoltaic projects in
Italy that have reached "ready to
build" status; and
- Fairfield Solar Project, LLC (13.44 MW), Malakoff Solar I,
LLC (6.96 MW) and Malakoff Solar II, LLC (6.96 MW), that are
constructing photovoltaic plants and Mexia Solar I, LLC (5.6 MW),
Mexia Solar II, LLC (5.6 MW), and Talco Solar, LLC (10.3 MW), that
are developing photovoltaic projects that have reached "ready to
build" status, all in the Dallas
Metropolitan area, Texas.
For more information about Ellomay, visit
http://www.ellomay.com.
Information Relating to Forward-Looking Statements
This press release contains forward-looking statements that
involve substantial risks and uncertainties, including statements
that are based on the current expectations and assumptions of the
Company's management. All statements, other than statements of
historical facts, included in this press release regarding the
Company's plans and objectives, expectations and assumptions of
management are forward-looking statements. The use of certain
words, including the words "estimate," "project," "intend,"
"expect," "believe" and similar expressions are intended to
identify forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. The Company may
not actually achieve the plans, intentions or expectations
disclosed in the forward-looking statements and you should not
place undue reliance on the Company's forward-looking statements.
Various important factors could cause actual results or events to
differ materially from those that may be expressed or implied by
the Company's forward-looking statements, including changes in
electricity prices and demand, continued war and hostilities in
Israel and Gaza, regulatory changes, including extension
of current or approval of new rules and regulations increasing the
operating expenses of manufacturers of renewable energy in
Spain, increases in interest rates
and inflation, changes in the supply and prices of resources
required for the operation of the Company's facilities (such as
waste and natural gas) and in the price of oil, the impact of
continued military conflict between Russia and Ukraine, technical and other disruptions in
the operations or construction of the power plants owned by the
Company and general market, political and economic conditions in
the countries in which the Company operates, including Israel, Spain, Italy
and the United States. These and
other risks and uncertainties associated with the Company's
business are described in greater detail in the filings the Company
makes from time to time with Securities and Exchange Commission,
including its Annual Report on Form 20-F. The forward-looking
statements are made as of this date and the Company does not
undertake any obligation to update any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Contact:
Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: hilai@ellomay.com
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Statements of Financial Position
|
|
|
March
31,
|
December
31,
|
March
31,
|
2024
|
2023
|
2024
|
Unaudited
|
Audited
|
Unaudited
|
€ in
thousands
|
Convenience
Translation
into US$ in thousands*
|
Assets
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
82,722
|
51,127
|
89,421
|
Short term
deposits
|
1,045
|
997
|
1,130
|
Restricted
cash
|
729
|
810
|
788
|
Intangible asset from
green certificates
|
436
|
553
|
471
|
Trade and other
receivables
|
12,229
|
11,717
|
13,219
|
Derivatives asset
short-term
|
1,403
|
275
|
1,517
|
Assets of disposal
groups classified as held for sale
|
27,959
|
28,297
|
30,223
|
|
126,523
|
93,776
|
136,769
|
Non-current
assets
|
|
|
|
Investment in equity
accounted investee
|
33,354
|
31,772
|
36,055
|
Advances on account of
investments
|
898
|
898
|
971
|
Fixed assets
|
421,149
|
407,982
|
455,255
|
Right-of-use
asset
|
31,738
|
30,967
|
34,308
|
Restricted cash and
deposits
|
16,343
|
17,386
|
17,667
|
Deferred tax
|
5,559
|
8,677
|
6,009
|
Long term
receivables
|
11,164
|
10,446
|
12,068
|
Derivatives
|
20,082
|
10,948
|
21,708
|
|
540,287
|
519,076
|
584,041
|
|
|
|
|
Total
assets
|
666,810
|
612,852
|
720,810
|
|
|
|
|
Liabilities and
Equity
|
|
|
|
Current
liabilities
|
|
|
|
Current maturities of
long-term bank loans
|
9,710
|
9,784
|
10,496
|
Current maturities of
long-term loans
|
5,000
|
5,000
|
5,405
|
Current maturities of
debentures
|
34,478
|
35,200
|
37,270
|
Trade
payables
|
9,159
|
5,249
|
9,900
|
Other
payables
|
14,357
|
10,859
|
15,520
|
Current maturities of
derivatives
|
-
|
4,643
|
-
|
Current maturities of
lease liabilities
|
741
|
700
|
801
|
Liabilities of disposal
groups classified as held for sale
|
17,409
|
17,142
|
18,819
|
|
90,854
|
88,577
|
98,211
|
Non-current
liabilities
|
|
|
|
Long-term lease
liabilities
|
24,488
|
23,680
|
26,471
|
Long-term bank
loans
|
238,999
|
237,781
|
258,354
|
Other long-term
loans
|
28,618
|
29,373
|
30,936
|
Debentures
|
144,633
|
104,887
|
156,346
|
Deferred tax
|
2,588
|
2,516
|
2,798
|
Other long-term
liabilities
|
4,379
|
939
|
4,734
|
|
443,705
|
399,176
|
479,639
|
Total
liabilities
|
534,559
|
487,753
|
577,850
|
Equity
|
|
|
|
Share
capital
|
25,613
|
25,613
|
27,687
|
Share
premium
|
86,189
|
86,159
|
93,169
|
Treasury
shares
|
(1,736)
|
(1,736)
|
(1,877)
|
Transaction reserve
with non-controlling Interests
|
5,697
|
5,697
|
6,158
|
Reserves
|
10,955
|
4,299
|
11,842
|
Accumulated
deficit
|
(8,650)
|
(5,037)
|
(9,351)
|
Total equity attributed
to shareholders of the
Company
|
118,068
|
114,995
|
127,628
|
Non-Controlling
Interest
|
14,183
|
10,104
|
15,332
|
Total
equity
|
132,251
|
125,099
|
142,960
|
Total liabilities
and equity
|
666,810
|
612,852
|
720,810
|
* Convenience
translation into US$ (exchange rate as at March 31, 2024: euro 1 =
US$ 1.081)
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Profit or Loss and Other
Comprehensive Income (Loss)
|
|
|
For the three months
ended March 31,
|
For the year
ended December 31,
|
For the three months
ended March 31,
|
2024
|
**2023
|
2023
|
2024
|
Unaudited
|
Audited
|
Unaudited
|
€ in thousands (except per share
data)
|
Convenience
Translation into
US$*
|
Revenues
|
8,243
|
11,733
|
48,834
|
8,911
|
Operating
expenses
|
(4,563)
|
(6,368)
|
(22,861)
|
(4,933)
|
Depreciation and
amortization expenses
|
(4,055)
|
(3,995)
|
(16,012)
|
(4,383)
|
Gross profit
(loss)
|
(375)
|
1,370
|
9,961
|
(405)
|
|
|
|
|
|
Project development
costs
|
(1,415)
|
(1,164)
|
(4,465)
|
(1,530)
|
General and
administrative expenses
|
(1,620)
|
(1,433)
|
(5,283)
|
(1,751)
|
Share of profits of
equity accounted investee
|
1,286
|
1,178
|
4,320
|
1,390
|
Operating profit
(loss)
|
(2,124)
|
(49)
|
4,533
|
(2,296)
|
|
|
|
|
|
Financing
income
|
631
|
4,747
|
8,747
|
682
|
Financing income in
connection with derivatives and warrants, net
|
536
|
86
|
251
|
579
|
Financing expenses in
connection with projects finance
|
(1,501)
|
(1,544)
|
(6,077)
|
(1,623)
|
Financing expenses in
connection with debentures
|
(1,711)
|
(828)
|
(3,876)
|
(1,850)
|
Interest expenses on
minority shareholder loan
|
(554)
|
(465)
|
(2,014)
|
(599)
|
Other financing
expenses
|
(713)
|
(267)
|
(588)
|
(771)
|
Financing income
(expenses), net
|
(3,312)
|
1,729
|
(3,557)
|
(3,582)
|
Profit (loss) before
taxes on income
|
(5,436)
|
1,680
|
976
|
(5,878)
|
Tax benefit
|
828
|
1,352
|
1,436
|
895
|
Profit (loss) from
continuing operations
|
(4,608)
|
3,032
|
2,412
|
(4,983)
|
Profit (loss) from
discontinued operation (net of tax)
|
(312)
|
242
|
(1,787)
|
(337)
|
Profit (loss) for
the period
|
(4,920)
|
3,274
|
625
|
(5,320)
|
Profit (loss)
attributable to:
|
|
|
|
|
Owners of the
Company
|
(3,613)
|
4,081
|
2,219
|
(3,906)
|
Non-controlling
interests
|
(1,307)
|
(807)
|
(1,594)
|
(1,414)
|
Profit (loss) for
the period
|
(4,920)
|
3,274
|
625
|
(5,320)
|
|
|
|
|
|
Other comprehensive
income items
|
|
|
|
|
That after initial
recognition in comprehensive income were
or will be transferred to profit or loss:
|
|
|
|
|
Foreign currency
translation differences for foreign operations
|
1,124
|
(5,550)
|
(7,949)
|
1,215
|
Effective portion of
change in fair value of cash flow hedges
|
10,461
|
34,405
|
39,431
|
11,308
|
Net change in fair
value of cash flow hedges
transferred to profit
or loss
|
457
|
(2,231)
|
9,794
|
494
|
Total other
comprehensive income
|
12,042
|
26,624
|
41,276
|
13,017
|
|
|
|
|
|
Total other
comprehensive income attributable to:
|
|
|
|
|
Owners of the
Company
|
6,656
|
11,015
|
16,931
|
7,195
|
Non-controlling
interests
|
5,386
|
15,609
|
24,345
|
5,822
|
Total other
comprehensive income
|
12,042
|
26,624
|
41,276
|
13,017
|
Total
comprehensive income for
the period
|
7,122
|
29,898
|
41,901
|
7,697
|
|
|
|
|
|
Total
comprehensive income for the
period attributable to:
|
|
|
|
|
Owners of the
Company
|
3,043
|
15,096
|
19,150
|
3,289
|
Non-controlling
interests
|
4,079
|
14,802
|
22,751
|
4,408
|
Total comprehensive
income for the period
|
7,122
|
29,898
|
41,901
|
7,697
|
|
|
|
|
|
* Convenience
translation into US$ (exchange rate as at March 31, 2024: euro 1 =
US$ 1.081)
|
** The results of the
Talmei Yosef solar plant have been reclassified as a discontinued
operation and the results for these periods have been adjusted
accordingly.
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Profit or Loss and Other
Comprehensive Income (Loss) (con't)
|
|
|
For the three months
ended March 31,
|
For the year
ended December 31,
|
For the three months
ended March 31,
|
2024
|
2023
|
2023
|
2024
|
Unaudited
|
Audited
|
Unaudited
|
€ in thousands (except per share
data)
|
Convenience
Translation into
US$*
|
|
|
|
|
|
Basic profit (loss)
per share
|
(0.28)
|
0.27
|
0.17
|
(0.31)
|
Diluted profit
(loss) per share
|
(0.28)
|
0.27
|
0.17
|
(0.31)
|
|
|
|
|
|
Basic profit (loss)
per share continuing operations
|
(0.31)
|
0.25
|
0.31
|
(0.34)
|
Diluted profit
(loss) per share continuing operations
|
(0.31)
|
0.25
|
0.31
|
(0.34)
|
|
|
|
|
|
Basic profit (loss)
per share discontinued operation
|
(0.02)
|
0.02
|
(0.14)
|
(0.02)
|
Diluted profit
(loss) per share discontinued operation
|
(0.02)
|
0.02
|
(0.14)
|
(0.02
|
* Convenience
translation into US$ (exchange rate as at March 31, 2023: euro 1 =
US$ 1.081)
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Changes in Equity
|
|
|
|
|
Attributable to
shareholders of the Company
|
Non-
controlling
|
Total
|
|
|
Interests
|
Equity
|
Share
capital
|
Share
premium
|
Accumulated
Deficit
|
Treasury
shares
|
Translation reserve
from
foreign
operations
|
Hedging
Reserve
|
Interests
Transaction reserve with
non-controlling
Interests
|
Total
|
|
|
€ in
thousands
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
|
|
|
|
|
|
|
|
|
ended March 31, 2024
(unaudited):
|
|
|
|
|
|
|
|
|
|
|
Balance as at
January 1, 2024
|
25,613
|
86,159
|
(5,037)
|
(1,736)
|
385
|
3,914
|
5,697
|
114,995
|
10,104
|
125,099
|
Loss for the
period
|
-
|
-
|
(3,613)
|
-
|
-
|
-
|
-
|
(3,613)
|
(1,307)
|
(4,920)
|
Other comprehensive
income for the period
|
-
|
-
|
-
|
-
|
1,088
|
5,568
|
-
|
6,656
|
5,386
|
12,042
|
Total comprehensive
income for the period
|
-
|
-
|
(3,613)
|
-
|
1,088
|
5,568
|
-
|
3,043
|
4,079
|
7,122
|
Transactions with
owners of the Company, recognized directly in
equity:
|
|
|
|
|
|
|
|
|
|
|
Share-based
payments
|
-
|
30
|
-
|
-
|
-
|
-
|
-
|
30
|
-
|
30
|
Balance as at March
31, 2024
|
25,613
|
86,189
|
(8,650)
|
(1,736)
|
1,473
|
9,482
|
5,697
|
118,068
|
14,183
|
132,251
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
|
|
|
|
|
|
|
|
|
ended March 31, 2023
(unaudited):
|
|
|
|
|
|
|
|
|
|
|
Balance as at January
1, 2023
|
25,613
|
86,038
|
(7,256)
|
(1,736)
|
7,970
|
(20,602)
|
5,697
|
95,724
|
(12,647)
|
83,077
|
Profit for the
period
|
-
|
-
|
4,081
|
-
|
-
|
-
|
-
|
4,081
|
(807)
|
3,274
|
Other comprehensive
income for the period
|
-
|
-
|
-
|
-
|
(5,292)
|
16,307
|
-
|
11,015
|
15,609
|
26,624
|
Total comprehensive
income for the period
|
-
|
-
|
4,081
|
-
|
(5,292)
|
16,307
|
-
|
15,096
|
14,802
|
29,898
|
Transactions with
owners of the Company,
recognized directly in equity:
|
|
|
|
|
|
|
|
|
|
|
Share-based
payments
|
-
|
31
|
-
|
-
|
-
|
-
|
-
|
31
|
-
|
31
|
Balance as at March 31,
2023
|
25,613
|
86,069
|
(3,175)
|
(1,736)
|
2,678
|
(4,295)
|
5,697
|
110,851
|
2,155
|
113,006
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Changes in Equity
(cont'd)
|
|
|
|
|
Attributable to
shareholders of the Company
|
Non-
controlling
|
Total
|
|
|
Interests
|
Equity
|
Share
capital
|
Share
premium
|
Accumulated
Deficit
|
Treasury
shares
|
Translation reserve
from
foreign
operations
|
Hedging
Reserve
|
Interests
Transaction reserve with
non-controlling
Interests
|
Total
|
|
|
€ in
thousands
|
For the year
ended
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023
(audited):
|
|
|
|
|
|
|
|
|
|
|
Balance as at
January 1, 2023
|
25,613
|
86,038
|
(7,256)
|
(1,736)
|
7,970
|
(20,602)
|
5,697
|
95,724
|
(12,647)
|
83,077
|
Profit for the
year
|
-
|
-
|
2,219
|
-
|
-
|
-
|
-
|
2,219
|
(1,594)
|
625
|
Other comprehensive
income for the year
|
-
|
-
|
-
|
-
|
(7,585)
|
24,516
|
-
|
16,931
|
24,345
|
41,276
|
Total comprehensive
income for the year
|
-
|
-
|
2,219
|
-
|
(7,585)
|
24,516
|
-
|
19,150
|
22,751
|
41,901
|
Transactions with
owners of the Company,
recognized directly in equity:
|
|
|
|
|
|
|
|
|
|
|
Share-based
payments
|
-
|
121
|
-
|
-
|
-
|
-
|
-
|
121
|
-
|
121
|
Balance as at
December 31, 2023
|
25,613
|
86,159
|
(5,037)
|
(1,736)
|
385
|
3,914
|
5,697
|
114,995
|
10,104
|
125,099
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Changes in Equity
(cont'd)
|
|
|
|
|
Attributable to
shareholders of the Company
|
Non-
controlling
|
Total
|
|
|
Interests
|
Equity
|
Share
capital
|
Share
premium
|
Accumulated
Deficit
|
Treasury
shares
|
Translation reserve
from
foreign
operations
|
Hedging
Reserve
|
Interests
Transaction reserve with
non-controlling
Interests
|
Total
|
|
|
Convenience
translation into US$ (exchange rate as at March 31, 2024: euro 1 =
US$ 1.081)
|
For the three
months
|
|
|
|
|
|
|
|
|
|
|
ended March 31, 2024
(unaudited):
|
|
|
|
|
|
|
|
|
|
|
Balance as at January 1, 2024
|
27,687
|
93,137
|
(5,445)
|
(1,877)
|
416
|
4,231
|
6,158
|
124,307
|
10,924
|
135,231
|
Loss for the
period
|
-
|
-
|
(3,906)
|
-
|
-
|
-
|
-
|
(3,906)
|
(1,414)
|
(5,320)
|
Other comprehensive
income for the period
|
-
|
-
|
-
|
-
|
1,176
|
6,019
|
-
|
7,195
|
5,822
|
13,017
|
Total comprehensive
income for the period
|
-
|
-
|
(3,906)
|
-
|
1,176
|
6,019
|
-
|
3,289
|
4,408
|
7,697
|
Transactions with
owners of the Company,
recognized directly in equity:
|
|
|
|
|
|
|
|
|
|
|
Share-based
payments
|
-
|
32
|
-
|
-
|
-
|
-
|
-
|
32
|
-
|
32
|
Balance as at March
31, 2024
|
27,687
|
93,169
|
(9,351)
|
(1,877)
|
1,592
|
10,250
|
6,158
|
127,628
|
15,332
|
142,960
|
|
|
|
|
|
|
|
|
|
|
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Condensed
Consolidated Interim Statements of Cash Flow
|
|
|
For the three
months
ended March 31,
|
For the year
ended December 31,
|
For the three
months
ended March 31,
|
2024
|
2023
|
2023
|
2024
|
Unaudited
|
Audited
|
Unaudited
|
€ in
thousands
|
Convenience
Translation into US$*
|
Cash flows from
operating activities
|
|
|
|
|
Profit (loss) for the
period
|
(4,920)
|
3,274
|
625
|
(5,320)
|
Adjustments
for:
|
|
|
|
|
Financing expenses
(income), net
|
3,167
|
(2,023)
|
3,034
|
3,425
|
Impairment losses on
assets of disposal groups classified as held-for-sale
|
601
|
-
|
2,565
|
650
|
Depreciation and
amortization
|
4,084
|
4,115
|
16,473
|
4,414
|
Share-based payment
transactions
|
30
|
31
|
121
|
32
|
Share of profit of
equity accounted investees
|
(1,286)
|
(1,178)
|
(4,320)
|
(1,390)
|
Payment of interest on
loan from an equity accounted investee
|
-
|
-
|
1,501
|
-
|
Change in trade
receivables and other receivables
|
(2,342)
|
(1,373)
|
(302)
|
(2,532)
|
Change in other
assets
|
-
|
(120)
|
(681)
|
-
|
Change in receivables
from concessions project
|
315
|
257
|
1,778
|
341
|
Change in trade
payables
|
(68)
|
(876)
|
(45)
|
(74)
|
Change in other
payables
|
2,796
|
1,417
|
(2,235)
|
3,022
|
Income tax
benefit
|
(805)
|
(1,256)
|
(1,852)
|
(870)
|
Income taxes refund
(paid)
|
564
|
-
|
(912)
|
610
|
Interest
received
|
907
|
493
|
2,936
|
980
|
Interest
paid
|
(1,892)
|
(923)
|
(10,082)
|
(2,045)
|
|
6,071
|
(1,436)
|
7,979
|
6,563
|
Net cash from operating
activities
|
1,151
|
1,838
|
8,604
|
1,243
|
|
|
|
|
|
Cash flows from
investing activities
|
|
|
|
|
Acquisition of fixed
assets
|
(9,020)
|
(13,331)
|
(58,848)
|
(9,750)
|
Interest paid
capitalized to fixed assets
|
-
|
-
|
(2,283)
|
-
|
Repayment of loan to an
equity accounted investee
|
-
|
-
|
1,324
|
-
|
Loan to an equity
accounted investee
|
-
|
(60)
|
(128)
|
-
|
Advances on account of
investments
|
-
|
(382)
|
(421)
|
-
|
Proceeds from advances
on account of investments
|
-
|
-
|
2,218
|
-
|
Proceeds in marketable
securities
|
-
|
2,837
|
2,837
|
-
|
Investment in
settlement of derivatives, net
|
14
|
-
|
-
|
15
|
Proceed from restricted
cash, net
|
1,153
|
893
|
840
|
1,246
|
Investment in
short-term deposits
|
(28)
|
(21,945)
|
(1,092)
|
(30)
|
Net cash used in
investing activities
|
(7,881)
|
(31,988)
|
(55,553)
|
(8,519)
|
|
|
|
|
|
Cash flows from
financing activities
|
|
|
|
|
Issuance of
warrants
|
3,735
|
-
|
-
|
4,037
|
Cost associated with
long term loans
|
(638)
|
(315)
|
(1,877)
|
(690)
|
Payment of principal of
lease liabilities
|
(299)
|
(200)
|
(1,156)
|
(323)
|
Proceeds from long-term
loans
|
380
|
764
|
32,157
|
411
|
Repayment of long-term
loans
|
(2,357)
|
(686)
|
(12,736)
|
(2,548)
|
Repayment of
debentures
|
-
|
-
|
(17,763)
|
-
|
Proceeds from issuance
of debentures, net
|
36,450
|
55,808
|
55,808
|
39,402
|
Net cash from
financing activities
|
37,271
|
55,371
|
54,433
|
40,289
|
|
|
|
|
|
Effect of exchange rate
fluctuations on cash and cash equivalents
|
1,667
|
(1,942)
|
(2,387)
|
1,804
|
Increase in cash and
cash equivalents
|
32,208
|
23,279
|
5,097
|
34,817
|
Cash and cash
equivalents at the beginning of year
|
51,555
|
46,458
|
46,458
|
55,730
|
Cash from disposal
groups classified as held-for-sale
|
(1,041)
|
-
|
(428)
|
(1,125)
|
Cash and cash
equivalents at the end of the period
|
82,722
|
69,737
|
51,127
|
89,422
|
* Convenience
translation into US$ (exchange rate as at March 31, 2024: euro 1 =
US$ 1.081)
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Operating
Segments
|
|
|
Italy
|
Spain
|
USA
|
Netherlands
|
Israel
|
Total
|
|
|
|
Subsidized
|
28 MV
|
|
|
|
|
|
|
reportable
|
|
Total
|
PV
|
Plants
|
PV
|
Talasol
|
PV
|
Biogas
|
Dorad
|
Manara
|
PV*
|
segments
|
Reconciliations
|
consolidated
|
For the three months ended March 31,
2024
|
€ in thousands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
71
|
740
|
245
|
3,180
|
-
|
4,007
|
14,392
|
-
|
288
|
22,923
|
(14,680)
|
8,243
|
Operating
expenses
|
-
|
(131)
|
(218)
|
(912)
|
-
|
(3,302)
|
(10,290)
|
-
|
(83)
|
(14,936)
|
10,373
|
(4,563)
|
Depreciation
expenses
|
-
|
(229)
|
(237)
|
(2,871)
|
-
|
(712)
|
(1,308)
|
-
|
(29)
|
(5,386)
|
1,331
|
(4,055)
|
Gross profit
(loss)
|
71
|
380
|
(210)
|
(603)
|
-
|
(7)
|
2,794
|
-
|
176
|
2,601
|
(2,976)
|
(375)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted gross
profit (loss)
|
71
|
380
|
(210)
|
(603)
|
-
|
(7)
|
2,794
|
-
|
(1,454)
|
971
|
(1,346)
|
(375)
|
Project development
costs
|
|
|
|
|
|
|
|
|
|
|
|
(1,415)
|
General and
administrative expenses
|
|
|
|
|
|
|
|
|
|
|
|
(1,620)
|
Share of loss of equity
accounted investee
|
|
|
|
|
|
|
|
|
|
|
|
1,286
|
Operating
profit
|
|
|
|
|
|
|
|
|
|
|
|
(2,124)
|
Financing
income
|
|
|
|
|
|
|
|
|
|
|
|
631
|
Financing income in
connection
|
|
|
|
|
|
|
|
|
|
|
|
|
with
derivatives and warrants,
net
|
|
|
|
|
|
|
|
|
|
|
|
536
|
Financing expenses in
connection with projects finance
|
|
|
|
|
|
|
|
|
|
|
|
(1,501)
|
Financing expenses in
connection with debentures
|
|
|
|
|
|
|
|
|
|
|
|
(1,711)
|
Interest expenses on
minority shareholder loan
|
|
|
|
|
|
|
|
|
|
|
|
(554)
|
Other financing
expenses
|
|
|
|
|
|
|
|
|
|
|
|
(713)
|
Financing expenses,
net
|
|
|
|
|
|
|
|
|
|
|
|
(3,312)
|
Loss before taxes on
income
|
|
|
|
|
|
|
|
|
|
|
|
(5,436)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets as at March 31,
2024
|
46,213
|
13,289
|
18,455
|
233,200
|
15,647
|
31,105
|
100,514
|
174,819
|
27,959
|
661,201
|
5,609
|
666,810
|
* The results of
the Talmei Yosef solar plant are presented as a discontinued
operation.
|
Ellomay Capital Ltd.
and its Subsidiaries
|
Reconciliation of
Profit (Loss) to EBITDA
|
|
|
For the three months
ended March 31,
|
For the year
ended December 31,
|
For the three months
ended March 31,
|
2024
|
**2023
|
2023
|
2024
|
€ in thousands
|
Convenience
Translation into US$*
|
Net profit (loss)
for the period
|
(4,920)
|
3,274
|
625
|
(5,320)
|
Financing expenses
(income), net
|
3,312
|
(1,729)
|
3,557
|
3,582
|
Tax
benefit
|
(828)
|
(1,352)
|
(1,436)
|
(895)
|
Depreciation and
amortization expenses
|
4,055
|
3,995
|
16,012
|
4,383
|
EBITDA
|
1,619
|
4,188
|
18,758
|
1,750
|
* Convenience
translation into US$ (exchange rate as at March 31, 2024: euro 1 =
US$ 1.081)
|
** The results of the
Talmei Yosef PV Plant have been reclassified as a discontinued
operation and the results for these periods have been adjusted
accordingly.
|
Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders
Financial Covenants
Pursuant to the Deeds of Trust governing the Company's Series C,
Series D, Series E and Series F Debentures (together, the
"Debentures"), the Company is required to maintain certain
financial covenants. For more information, see Items 4.A and 5.B of
the Company's Annual Report on Form 20-F submitted to the
Securities and Exchange Commission on April
7, 2023, and below.
Net Financial Debt
As of March 31, 2024, the
Company's Net Financial Debt, (as such term is defined in the Deeds
of Trust of the Company's Debentures), was approximately €102.5
million (consisting of approximately €300.22 million of
short-term and long-term debt from banks and other interest bearing
financial obligations, approximately €186.33 million in
connection with the Series C Debentures issuances (in July 2019, October
2020, February 2021 and
October 2021), the Series D
Convertible Debentures issuance (in February
2021), the Series E Secured Debentures issuance (in
February 2023) and the Series F
Debentures issuance (in January
2024)), net of approximately €83.8 million of cash and cash
equivalents, short-term deposits and marketable securities and net
of approximately €300.24 million of project finance and
related hedging transactions of the Company's subsidiaries).
Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)
Information for the Company's Series C Debenture
Holders.
The Deed of Trust governing the Company's Series C Debentures
(as amended on June 6, 2022, the
"Series C Deed of Trust"), includes an undertaking by the
Company to maintain certain financial covenants, whereby a breach
of such financial covenants for two consecutive quarters is a cause
for immediate repayment. As of March 31, 2024, the Company
was in compliance with the financial covenants set forth in the
Series C Deed of Trust as follows: (i) the Company's Adjusted
Shareholders' Equity (as defined in the Series C Deed of Trust) was
approximately €117.1 million, (ii) the ratio of the Company's Net
Financial Debt (as set forth above) to the Company's CAP, Net
(defined as the Company's Adjusted Shareholders' Equity plus the
Net Financial Debt) was 46.7%, and (iii) the ratio of the Company's
Net Financial Debt to the Company's Adjusted EBITDA5,
was 5.5.
The following is a reconciliation between the Company's profit
and the Adjusted EBITDA (as defined in the Series C Deed of Trust)
for the four-quarter period ended March 31,
2024:
|
For the four-quarter period
ended March 31, 2024
|
Unaudited
|
€ in thousands
|
Loss for the
period
|
(7,569)
|
Financing expenses,
net
|
8,892
|
Tax benefit
|
(1,008)
|
Depreciation and
amortization expenses
|
15,952
|
Share-based
payments
|
120
|
Adjustment to revenues
of the Talmei Yosef PV Plant due to
calculation based on the fixed asset model
|
2,331
|
Adjusted EBITDA as
defined the Series C Deed of Trust
|
18,718
|
Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)
Information for the Company's Series D Debenture
Holders
The Deed of Trust governing the Company's Series D Debentures
includes an undertaking by the Company to maintain certain
financial covenants, whereby a breach of such financial covenants
for the periods set forth in the Series D Deed of Trust is a cause
for immediate repayment. As of March 31,
2024, the Company was in compliance with the financial
covenants set forth in the Series D Deed of Trust as follows: (i)
the Company's Adjusted Shareholders' Equity (as defined in the
Series D Deed of Trust) was approximately €117.1 million, (ii) the
ratio of the Company's Net Financial Debt (as set forth above) to
the Company's CAP, Net (defined as the Company's Adjusted
Shareholders' Equity plus the Net Financial Debt) was 46.7%, and
(iii) the ratio of the Company's Net Financial Debt to the
Company's Adjusted EBITDA6 was 5.5.
The following is a reconciliation between the Company's profit
and the Adjusted EBITDA (as defined in the Series D Deed of Trust)
for the four-quarter period ended March
31, 2024:
|
For the four-quarter period
ended March 31, 2024
|
Unaudited
|
€ in thousands
|
Loss for the
period
|
(7,569)
|
Financing expenses,
net
|
8,892
|
Tax benefit
|
(1,008)
|
Depreciation and
amortization expenses
|
15,952
|
Share-based
payments
|
120
|
Adjustment to revenues
of the Talmei Yosef PV Plant due to
calculation based on the fixed asset model
|
2,331
|
Adjusted EBITDA as
defined the Series D Deed of Trust
|
18,718
|
Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)
Information for the Company's Series E Debenture
Holders
The Deed of Trust governing the Company's Series E Debentures
includes an undertaking by the Company to maintain certain
financial covenants, whereby a breach of such financial covenants
for the periods set forth in the Series E Deed of Trust is a cause
for immediate repayment. As of March 31,
2024, the Company was in compliance with the financial
covenants set forth in the Series E Deed of Trust as follows: (i)
the Company's Adjusted Shareholders' Equity (as defined in the
Series E Deed of Trust) was approximately €117.1 million, (ii) the
ratio of the Company's Net Financial Debt (as set forth above) to
the Company's CAP, Net (defined as the Company's Adjusted
Shareholders' Equity plus the Net Financial Debt) was 46.7%, and
(iii) the ratio of the Company's Net Financial Debt to the
Company's Adjusted EBITDA7 was 5.5.
The following is a reconciliation between the Company's profit
and the Adjusted EBITDA (as defined in the Series E Deed of Trust)
for the four-quarter period ended March
31, 2024:
|
For the four-quarter period
ended March 31, 2024
|
Unaudited
|
€ in thousands
|
Loss for the
period
|
(7,569)
|
Financing expenses,
net
|
8,892
|
Tax benefit
|
(1,008)
|
Depreciation and
amortization expenses
|
15,952
|
Share-based
payments
|
120
|
Adjustment to revenues
of the Talmei Yosef PV Plant due to
calculation based on the fixed asset model
|
2,331
|
Adjusted EBITDA as
defined the Series E Deed of Trust
|
18,718
|
In connection with the undertaking included in Section 3.17.2 of
Annex 6 of the Series E Deed of Trust, no circumstances occurred
during the reporting period under which the rights to loans
provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U.
Dori Energy Infrastructures Ltd. ("Ellomay Luzon Energy")),
which were pledged to the holders of the Company's Series E
Debentures, will become subordinate to the amounts owed by Ellomay
Luzon Energy to Israel Discount Bank Ltd.
As of March 31, 2024, the value of
the assets pledged to the holders of the Series E Debentures in the
Company's books (unaudited) is approximately €33.4 million
(approximately NIS132.7 million based
on the exchange rate as of such date).
Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)
Information for the Company's Series F Debenture
Holders
The Deed of Trust governing the Company's Series F Debentures
includes an undertaking by the Company to maintain certain
financial covenants, whereby a breach of such financial covenants
for the periods set forth in the Series F Deed of Trust is a cause
for immediate repayment. As of March 31,
2024, the Company was in compliance with the financial
covenants set forth in the Series F Deed of Trust as follows: (i)
the Company's Adjusted Shareholders' Equity (as defined in the
Series F Deed of Trust) was approximately €116.2 million, (ii) the
ratio of the Company's Net Financial Debt (as set forth above) to
the Company's CAP, Net (defined as the Company's Adjusted
Shareholders' Equity plus the Net Financial Debt) was 46.9%, and
(iii) the ratio of the Company's Net Financial Debt to the
Company's Adjusted EBITDA8 was 5.5.
The following is a reconciliation between the Company's profit
and the Adjusted EBITDA (as defined in the Series F Deed of Trust)
for the four-quarter period ended March
31, 2024:
|
For the four-quarter period
ended March 31, 2024
|
Unaudited
|
€ in thousands
|
Loss for the
period
|
(7,569)
|
Financing expenses,
net
|
8,892
|
Tax benefit
|
(1,008)
|
Depreciation and
amortization expenses
|
15,952
|
Share-based
payments
|
120
|
Adjustment to revenues
of the Talmei Yosef PV Plant due to
calculation based on the fixed asset model
|
2,331
|
Adjusted EBITDA as
defined the Series F Deed of Trust
|
18,718
|
- The revenues presented in the Company's financial results
included in this press release are based on IFRS and do not take
into account the adjustments included in the Company's investor
presentation.
- The amount of short-term and long-term debt from banks
and other interest-bearing financial obligations provided above,
includes an amount of approximately €4.7 million costs associated
with such debt, which was capitalized and therefore offset from the
debt amount that is recorded in the Company's balance
sheet.
- The amount of the debentures provided above includes an amount
of approximately €1.6 million associated costs, which was
capitalized and therefore offset from the debentures amount that is
recorded in the Company's balance sheet.
- The project finance amount deducted from the calculation
of Net Financial Debt includes project finance obtained from
various sources, including financing entities and the minority
shareholders in project companies held by the Company (provided in
the form of shareholders' loans to the project companies).
- The term "Adjusted EBITDA" is defined in the Series C Deed of
Trust as earnings before financial expenses, net, taxes,
depreciation and amortization, where the revenues from the
Company's operations, such as the Talmei Yosef PV Plant, are
calculated based on the fixed asset model and not based on the
financial asset model (IFRIC 12), and before share-based payments.
The Series C Deed of Trust provides that for purposes of the
financial covenant, the Adjusted EBITDA will be calculated based on
the four preceding quarters, in the aggregate. The Adjusted EBITDA
is presented in this press release as part of the Company's
undertakings towards the holders of its Series C Debentures. For a
general discussion of the use of non-IFRS measures, such as EBITDA
and Adjusted EBITDA see above under "Use of Non-IFRS Financial
Measures."
- The term "Adjusted EBITDA" is defined in the Series D Deed of
Trust as earnings before financial expenses, net, taxes,
depreciation and amortization, where the revenues from the
Company's operations, such as the Talmei Yosef PV Plant, are
calculated based on the fixed asset model and not based on the
financial asset model (IFRIC 12), and before share-based payments,
when the data of assets or projects whose Commercial Operation Date
(as such term is defined in the Series D Deed of Trust) occurred in
the four quarters that preceded the relevant date will be
calculated based on Annual Gross Up (as such term is defined in the
Series D Deed of Trust). The Series D Deed of Trust provides that
for purposes of the financial covenant, the Adjusted EBITDA will be
calculated based on the four preceding quarters, in the aggregate.
The Adjusted EBITDA is presented in this press release as part of
the Company's undertakings towards the holders of its Series D
Debentures. For a general discussion of the use of non-IFRS
measures, such as EBITDA and Adjusted EBITDA see above under "Use
of Non-IFRS Financial Measures."
- The term "Adjusted EBITDA" is defined in the Series E Deed of
Trust as earnings before financial expenses, net, taxes,
depreciation and amortization, where the revenues from the
Company's operations, such as the Talmei Yosef PV Plant, are
calculated based on the fixed asset model and not based on the
financial asset model (IFRIC 12), and before share-based payments,
when the data of assets or projects whose Commercial Operation Date
(as such term is defined in the Series E Deed of Trust) occurred in
the four quarters that preceded the relevant date will be
calculated based on Annual Gross Up (as such term is defined in the
Series E Deed of Trust). The Series E Deed of Trust provides that
for purposes of the financial covenant, the Adjusted EBITDA will be
calculated based on the four preceding quarters, in the aggregate.
The Adjusted EBITDA is presented in this press release as part of
the Company's undertakings towards the holders of its Series E
Debentures. For a general discussion of the use of non-IFRS
measures, such as EBITDA and Adjusted EBITDA see above under "Use
of Non-IFRS Financial Measures."
- The term "Adjusted EBITDA" is defined in the Series F Deed of
Trust as earnings before financial expenses, net, taxes,
depreciation and amortization, where the revenues from the
Company's operations, such as the Talmei Yosef PV Plant, are
calculated based on the fixed asset model and not based on the
financial asset model (IFRIC 12), and before share-based payments,
when the data of assets or projects whose Commercial Operation Date
(as such term is defined in the Series F Deed of Trust) occurred in
the four quarters that preceded the relevant date will be
calculated based on Annual Gross Up (as such term is defined in the
Series F Deed of Trust). The Series F Deed of Trust provides that
for purposes of the financial covenant, the Adjusted EBITDA will be
calculated based on the four preceding quarters, in the aggregate.
The Adjusted EBITDA is presented in this press release as part of
the Company's undertakings towards the holders of its Series F
Debentures. For a general discussion of the use of non-IFRS
measures, such as EBITDA and Adjusted EBITDA see above under "Use
of Non-IFRS Financial Measures."
View original
content:https://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-three-months-ended-march-31-2024-302186409.html
SOURCE Ellomay Capital Ltd.